Home Log In
Tuesday, October 6, 2026
28.3
C
Bengaluru
Hot topics
DiME (Digi MarketEr):-TiME to SHiNE
The new sparkling DIME (Digi MarketEr) are the ones who embrace digital transformation with open arms and voraciously feed on data analytics to satisfy their performance outcomes with an informed business decision. The benefit of being DIME is that it propels data management out of the hands of individual stakeholders, and puts data sets with insights on to center glass table (Transparent workplace) for informed decision making.
The ‘Amazonization’ of Healthcare
Inside this Issue
1. The 'Amazonization' of Healthcare by Salil Kallianpur
Amazon's drive...
Healthcare Disruption – Will Ola, Swiggy, Pharmaeasy, and Hospitals Converge to Deliver Health Care on Call at Your Doorstep?
How long before digital Unicorns like Ola, Swiggy, Pharmeasy, and many others realize the humongous opportunity of delivering health care at the doorstep?
Imagine an app like Ola, where instead of entering where you want to go, you enter the nature of your medical need/emergency and search and find a range of hospitals/doctors/paramedics who can act as the first responders and reach your home in an ambulance or a motorbike with an HCP as a pillion rider with all necessary equipment from the thermometer to defibrillator depending on the nature of the medical care needed and triage and route you/your loved ones to the nearest hospital with an indicative cost of treatment in partnership with health insurance companies?
A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act
Sun Pharma’s Odyssey and Organon’s Second Act – And...
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
Hot topics
Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.
With over 25 years of leadership experience across commercial...
Don’t Do Digital for the Sake of Doing Digital
Catalyzed by the pandemic, the pharma industry quickly progressed from being digitally agnostic to a state of preparedness.
The shift required the industry to experiment with technology in its customer-facing plans, which resulted in many cases the creation of random acts of digital, often without a cohesive overarching strategy.
Can pharma do better? The answer lies in understanding the utility of their digital assets while building a mindset to transform, and ensuring that teams within the organization do not work at cross-purposes.
Breaking Performance Barriers
Articles by K. Hariram, Pankaj Mehrotra, Rinkesh Shah, Gopal Kishore, Amaninder S. Dhillon, Ramandish Arora, Mohit Kumar Bhutani, Richa Goyal, and Mahendra Kumar Rai
Indian Pharma Power 23
By MedicinMan Editorial Team
India’s pharmaceutical dominance doesn’t rest on...
Crafting a Digital Strategy: The Roadmap for 2021
In many situations, technology upgradation is often construed as digital transformation. In a recently conducted survey by Altimeter, 88% of companies said that they were undergoing ‘digital transformation’ but only 25% said that they did so with the purpose beyond investing in new technology. The real definition of digital transformation is the realignment of, or new investment in technology, business models, and processes to create value for customers in a dynamic digital economy.
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
Newsletter
Get important news delivered directly to your inbox and stay connected!